WGO Graded Evidence: Management of Acute Viral Hepatitis

Level: Cascade and Global Epidemiology: 18 Abstracts

Legend:   no star : Special Mention | : Important | : Very Important | : Key Development
	Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin inurban minority patients. Feuerstadt P, Bunim AL, Garcia H, Karlitz JJ, Massoumi H, Thosani AJ, Pellecchia A, Wolkoff AW, Gaglio PJ, Reinus JF., Hepatology. 2010 Apr;51(4):1137-43.
	Adverse outcomes in Alaska natives who recovered from or have chronic hepatitis Cinfection. McMahon BJ, Bruden D, Bruce MG, Livingston S, Christensen C, Homan C, HennessyTW, Williams J, Sullivan D, Rosen HR, Gretch D., Gastroenterology. 2010 Mar;138(3):922-31.e1. Epub 2009 Nov 10.
	Hepatitis B virus infection among American patients with chronic hepatitis Cvirus infection: prevalence, racial/ethnic differences, and viral interactions. Bini EJ, Perumalswami PV., Hepatology. 2010 Mar;51(3):759-66.
	Factors associated with rapid and early virologic response to peginterferonalfa-2a/ribavirin treatment in HCV genotype 1 patients representative of thegeneral chronic hepatitis C population. Rodriguez-Torres M, Sulkowski MS, Chung RT, Hamzeh FM, Jensen DM., J Viral Hepat. 2010 Feb 1;17(2):139-47. Epub 2009 Aug 5.
	Screening and early treatment of migrants for chronic hepatitis B virus infectionis cost-effective. Veldhuijzen IK, Toy M, Hahné SJ, De Wit GA, Schalm SW, de Man RA, Richardus JH., Gastroenterology. 2010 Feb;138(2):522-30. Epub 2009 Oct 29.
	Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa. Mendy ME, Welzel T, Lesi OA, Hainaut P, Hall AJ, Kuniholm MH, McConkey S, GoedertJJ, Kaye S, Rowland-Jones S, Whittle H, Kirk GD., J Viral Hepat. 2010 Feb 1;17(2):115-22. Epub 2009 Oct 27.
	Equally poor outcomes to pegylated interferon-based therapy in African Americans and Hispanics with chronic hepatitis C infection. Satapathy SK, Lingisetty CS, Proper S, Chaudhari S, Williams S., J Clin Gastroenterol. 2010 Feb;44(2):140-5.
	Initial thrombocytopenia as a simple, valuable predictor for clinical manifestation in acute hepatitis A. Kim HS, Kim HS, Lee JY, Jang JS, Shin WG, Kim KH, Park JY, Lee JH, Kim HY, Jang MK, Scand J Gastroenterol. 2008 Jan;43(1):81-8
	Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003. Tanaka H, Imai Y, Hiramatsu N, Ito Y, Imanaka K, Oshita M, Hijioka T, Katayama K, Yabuuchi I, Yoshihara H, Inoue A, Kato M, Takehara T, Tamura S, Kasahara A, Hayashi N, Tsukuma H Ann Intern Med.
	Survival in Asian Americans after treatments for hepatocellular carcinoma: aseven-year experience at UCLA. Tong MJ, Chavalitdhamrong D, Lu DS, Raman SS, Gomes A, Duffy JP, Hong JC,Busuttil RW., J Clin Gastroenterol. 2010 Mar;44(3):e63-70.
	Ethnicity and body mass index are associated with hepatitis C presentation andprogression. Kallwitz ER, Layden-Almer J, Dhamija M, Berkes J, Guzman G, Lepe R, Cotler SJ,Layden TJ., Clin Gastroenterol Hepatol. 2010 Jan;8(1):72-8. Epub 2009 Aug 15.
	Hepatitis E-associated acute liver failure in pregnancy: an Indian puzzle. Bernuau J, Nicand E, Durand F, Hepatology. 2008 Nov;48(5):1380-2
	Human leukocyte antigen class II associations with hepatitis C virus clearance and virus-specific CD4 T cell response among Caucasians and African Americans. Harris RA, Sugimoto K, Kaplan DE, Ikeda F, Kamoun M, Chang KM Hepatology. 2008 Jul;48(1):70-9
Supplementary evidence:
	Distribution of hepatitis C prevalence in individuals according to their age level in Eastern Turkey. Bozkurt H, Kurtoglu MG, Bayram Y, Kesli R, Berktas M, Eur J Gastroenterol Hepatol. 2008 Dec;20(12):1249
	High impact of migration on the prevalence of chronic hepatitis B in the Netherlands. Marschall T, Kretzschmar M, Mangen MJ, Schalm S, Eur J Gastroenterol Hepatol. 2008 Dec;20(12):1214-25
	Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China. Guo X, Jin Y, Qian G, Tu H, J Hepatol. 2008 Nov;49(5):718-25
	Does hepatitis E viral load and genotypes influence the final outcome of acute liver failure during pregnancy? Kar P, Jilani N, Husain SA, Pasha ST, Anand R, Rai A, Das BC, Am J Gastroenterol. 2008 Oct;103(10):2495-501
	HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma. Yuen MF, Wong DK, Fung J, Ip P, But D, Hung I, Lau K, Yuen JC, Lai CL, Gastroenterology. 2008 Oct;135(4):1192-9